The phrase "a different solid" is correct and usable in written English.
It can be used when referring to an alternative solid object or material in a comparison or discussion.
Example: "In this experiment, we will compare the properties of a different solid to the one we used previously."
Alternatives: "another solid" or "an alternative solid".
Another winning startup, REEcycle, has its eye on a different solid waste stream.
The set designer for "Helga," Lenore Doxsee, had put a white covering on the floor and stretched white fabric the length of the back of the space; the figures, each in a different solid color, were like bold brushstrokes on a blank canvas, and they jolted us into the piece.
Simulations for rapidly heating a fresh sample show multiple peaks in the liquid depth vs time curve, each corresponding to a different solid phase composition.
The deepest core sample within lithologic unit 5 (brown mudstone) consists mainly of subducting pelagic clays and clearly shows a lower grain density, suggesting a different solid composition, for example, more clay minerals and volcaniclastic grains.
Two binders (polyethylene glycol (PEG) and Soluplus®) with a different solid state, semi-crystalline vs amorphous respectively, were combined with two model-drugs, metoprolol tartrate (MPT) and caffeine anhydrous (CAF), both having a contrasting miscibility with the binders.
Each page of SPLAT! consists of a different solid, bright color and the beginning and end of a visually interactive pun.
2. Richard L. Ridge and Roderick R. Denault boldly upholstered four identical club chairs from Brun schwig & Fils, each in a different solid-color Brun schwig fabric ($46.50 to $148.50 a yard).
The average LRS determined for the present S2 devices was slightly higher than that previously reported (0.14 /CC), which was due to both the series resistance of the Ti nanolayer and use of a different solid-electrolyte.
Inhibition of angiogenesis has emerged as an effective therapy with acceptable tolerability in a variety of different solid tumours, including colorectal cancer (Hurwitz et al, 2004), NSCLC (Sandler et al, 2006), and breast cancer (Miller et al, 2007).
In addition, data from a study investigating long-term treatment with bevacizumab in patients with a range of different solid tumors suggest that bevacizumab-related hypertension decreases with long-term use (Langmuir et al. 2002).
Furthermore, since the therapeutic target is independent of the tumor type, the vaccine may potentially be active against a variety of different solid malignancies.
